Stock market news

Ozon Pharmaceuticals

Ozone Pharmaceuticals' RAS net profit for 3 months of 2025 amounted to ₽0.429 billion, down 2.8 times from ₽1.2 billion in the previous year. Revenue fell 41.5% to ₽0.708 billion against ₽1.21 billion a year earlier.

MOEX Group (Moscow Exchange)

Number of private investors on Moscow Exchange in April 2025 increased by 399 thousand and reached 36.7 million. Transactions on the stock market in April were concluded by 3.6 million people. Share of individuals in the volume of trading in shares and units amounted to 74.7%, bonds - 31.5%. In trades on OTC market of OTC shares with CC the stake of private...

MGKL

Resale Market platform continues to actively develop in volume and coverage. New categories include children's goods, health and beauty products. Expanding the assortment allows us to strengthen our reach in such key segments as: young families, for whom the availability of children's goods is important; female audience, focused on rational choice in the car...

Zaymer

Board of Directors of Zaymer recommended that dividends be paid for 3 months 2025 in the amount of ₽4.58 per ordinary share. The last day of the purchase of securities to receive dividends is June 26, 2025. Dividend yield may amount to 2.98%.

Zaymer

MFK Zaimer's IFRS net profit for 3 months of 2025 amounted to ₽915.7 million, up 2-fold from ₽458.9 million in the previous year. Net interest income rose 13.6% to ₽5 billion vs. ₽4.4 billion a year earlier.

Territorial Generating Company № 14

Territorial Generation Company No. 14's RAS net profit for 3 months of 2025 amounted to ₽588.5 million, up 46.6% from ₽401.4 million in the previous year. Revenue rose 15.5% to ₽6.7 billion vs. ₽5.8 billion a year earlier.

JetLend

JetLend's revenue in April 2025 amounted to ₽43.3 million. Loan origination fee income reached ₽36.6 million and other income reached ₽6.7 million. For the full year 2025, the company expects to earn ₽833 million in revenue and generate ₽119.4 million in net income.

Polyus

Polyus' RAS net profit for 3 months of 2025 amounted to ₽96.25 billion, up 67 times from ₽1.43 billion in the previous year. Growth of the indicator was due to the appearance of income from participation in other organizations in the amount of ₽99.3 billion in the reporting period.

Artgen

Artgen's Board of Directors recommended not to pay dividends due to tight monetary policy and the challenges associated with continuing to finance the drugs under development.

Zvezda

Zvezda's RAS loss for 3 months of 2025 amounted to ₽251 million, down 11.9% from ₽285 million in the previous year. Revenue decreased by 1.8% to ₽902 million vs. ₽919 million a year earlier.